Navigation Links
OncoGenex Reports Third Quarter Financial Results
Date:11/10/2008

FDA stated that it

agreed with the design and planned analysis proposed by OncoGenex,

and that the study design adequately addresses the objectives

necessary to support a regulatory submission.

- Sonus signed an exclusive in-licensing agreement with Bayer

HealthCare LLC for development of a family of compounds known as

caspase activators presently in preclinical research. As the caspase

family of proteases plays essential roles in apoptosis, the caspase

activators offer the potential for the development of therapies in

the treatment of various cancers.

- OncoGenex received Fast Track designation from the FDA for

development of OGX-011 in combination with docetaxel for progressive

metastatic prostate cancer. Fast Track designation was granted on the

basis that OGX-011 may provide a significant improvement in the

safety or effectiveness of the treatment for a serious or life-

threatening disease. Based on this designation, the FDA will take

actions as appropriate to expedite the development and review of OGX-

011 for approval. These actions include scheduled meetings to obtain

FDA input into development plans, the option of submitting a New Drug

Application in sections rather than all components simultaneously,

and the option of requesting evaluation of studies using surrogate

endpoints.

- On October 7, 2008 OncoGenex and the FDA concluded a meeting whereby

the FDA agreed that "durable pain palliation is an acceptable and

desirable study endpoint" to support a product marketing approval for

OGX-011 as a treatment for hormone refractory prostate cancer (HRPC).

In addition, the FDA provided guidance on the submitted protocol

including recommendations on study endpoints, the appropriate patient

pop
'/>"/>

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer
2. Sonus Pharmaceuticals and OncoGenex Technologies to Merge
3. OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference
4. OncoGenex increases economic interest in lead cancer drug OGX-011
5. OncoGenex receives completed Special Protocol Assessment for primary registration study of lead drug candidate OGX-011
6. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
7. FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals Lead Product Candidate OGX-011
8. OncoGenex Pharmaceuticals announces out-license of TOCOSOL Paclitaxel to Eagle Pharmaceuticals
9. OncoGenex To Present At The BioContact Quebec 2008 Annual Conference
10. OncoGenex Achieves Key Regulatory Milestone for Lead Product Candidate, OGX-011
11. OncoGenex Pharmaceuticals to Release Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Calif. (PRWEB) August 19, 2014 ... campaign to raise $200,000 to fund a corporate ... device. , This development is a critical ... model of care to the implementation of personalized ... method of practicing medicine. , Indiegogo contributions will ...
(Date:8/19/2014)... La Jolla, CA (PRWEB) August 19, 2014 ... the toll Parkinson’s disease can take on an individual. ... tremoring extremities, decreased facial expression, problems swallowing and severe ... due to the dying off of dopamine producing neurons ... retain themselves from a disease that slowly and progressively ...
(Date:8/19/2014)... Aug. 19, 2014 Research ... of the "Spectroscopy Equipment and Accessories ... to their offering. This ... Equipment and Accessories in US$ Thousands by ... spectrophotometers, Raman Spectrometers, NMR-EPR Spectrometers, Near Infrared ...
(Date:8/19/2014)... 2012, the European Union (EU) mandated use of the ICH-recommended ... – responding to the increasing need to understand and manage ... many regions, the main objectives of the PBRER are to:, ... of new or emerging information on the risks of a ... potential benefits of a drug; and , Allow ...
Breaking Biology Technology:Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 2Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 3As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 2As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 3Global Spectroscopy Equipment and Accessories - Strategic Business Report 2014 2Top Five Best Practices for Developing Your Periodic Benefit Risk Evaluation Report (PBRER), New Webinar Hosted by Xtalks 2
... Programs Supported by a Grant from Otsuka ... America Pharmaceutical, Inc., ROCKVILLE, ... nonprofit organizations and one individual,as the recipients of the fifth annual ... the 2008 APF Annual Benefit in,Washington, D.C. Each organization or individual ...
... leader in room,temperature biological sample stabilization, announced today that ... Sales and Marketing.,Biomatrica,s interim Vice President of Sales and ... company and will continue to serve as,an advisor on ... years of sales and marketing experience in,the biotech industry. ...
... wastage by saving the patient,s own whole blood, ... a journal for,perfusionists, the health professionals who manage patients ... reports how Global Blood,Resources, online waste calculator can be ... the "cell washing" machines most commonly used,during heart surgery ...
Cached Biology Technology:American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 2American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 3American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 4American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 5Trisha Dowling Joins Biomatrica as Vice President, Sales and Marketing 2Global Blood Resources' On-Line Calculator Reveals Wasted Blood Costs by Blood Salvage Machines During Heart Surgery to be in the Billions 2Global Blood Resources' On-Line Calculator Reveals Wasted Blood Costs by Blood Salvage Machines During Heart Surgery to be in the Billions 3
(Date:8/19/2014)... a monkey. It,s not a lemur. It,s not an African ... tarsier: a tiny, adorable and downright "cool" primate from Southeast ... are familiar with," said Rafe Brown, curator-in-charge at the University ... ears; an extremely cute, furry body; a long tail with ... and toe tips that look a bit like the disks ...
(Date:8/19/2014)... chemical engineers have devised a new implantable tissue scaffold ... over a few weeks. When applied to bone injuries ... rapidly form new bone that looks and behaves just ... scaffold could offer a dramatic improvement over the current ... from another part of the patient,s body a ...
(Date:8/19/2014)... -- ( Aug. 19, 2014 ) -- Scientists at ... to pick up and transfer single cells using a ... slightly. They describe this engineering feat and preliminary test ... of the American Chemical Society . , "Studying single ... in current biomedical research," said nanomedicine department. faculty member ...
Breaking Biology News(10 mins):Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety 2Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety 3Engineering new bone growth 2Engineering new bone growth 3Moving single cells around -- accurately and cheaply 2
... China, a team of genome researchers has concluded in a ... large-scale gene re-sequencing. Their findings, which appear in the latest ... Sciences ( PNAS ), indicate that domesticated rice may ... ago in the Yangtze Valley of China. Previous research suggested ...
... itch adds to growing evidence that the chemical signals that ... make us wince in pain. The interactions between itch ... researcher Diana Bautista, an assistant professor of molecular and cell ... some nerve cells that respond only to itch and others ...
... after experts apply an extensive array of approaches. An ... rapidly determined the structure of protein molecules in several cases ... of the new method is reported May 1 in ... Dr. Frank DiMaio of the University of Washington (UW) in ...
Cached Biology News:Rice's origins point to China, genome researchers conclude 2Rice's origins point to China, genome researchers conclude 3Pain and itch connected down deep 2Pain and itch connected down deep 3Pain and itch connected down deep 4Several baffling puzzles in protein molecular structure solved with new method 2Several baffling puzzles in protein molecular structure solved with new method 3Several baffling puzzles in protein molecular structure solved with new method 4
Rabbit Anti-Human Janus Kinase 2 (JAK2 Polyclonal Antibody Family: Protein Kinase Sub-Family: TYK2/JAK Applications: ELISA, Western Blot...
MAb to HSV-2, gG-2 HSV-2 Glycoprotein G-2...
Immunogen for A300-655A was a phosphorylated synthetic peptide, which represented a portion of human RNA Polymerase II (GeneID 5430) around serine 5 of the C-terminal repeat YSPTSPS....
human Exodus-2 Research Focus: cytokine/growth factor Storage Temperature: -20C Shipping Temperature: 4C...
Biology Products: